Molecular and Cytogenetic Profiling of Therapy-Related Myeloid Neoplasms (t-MN) versus Primary Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)

被引：0
|
作者：
Zhou, Yi Yuan [1 ]
Jajosky, Audrey [2 ]
Sadri, Navid
Beck, Rose [1 ]
机构：
[1] Case Western Reserve Univ, Univ Hosp Cleveland, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1501
引用
收藏
页码：1416 / 1417
页数：2
相关论文
共 50 条
  • [11] Therapy-Related Myeloid Neoplasms (t-MN) in Chronic Lymphocytic Leukemia Patients Treated with the FCR Chemotherapy Regimen
    Zhou, Y.
    Tang, G.
    Ok, C. Y.
    Medeiros, L. J.
    Wierda, W.
    Wang, S. A.
    LABORATORY INVESTIGATION, 2011, 91 : 334A - 334A
  • [12] Therapy-Related Myeloid Neoplasms (t-MN) in Chronic Lymphocytic Leukemia Patients Treated with the FCR Chemotherapy Regimen
    Zhou, Y.
    Tang, G.
    Ok, C. Y.
    Medeiros, L. J.
    Wierda, W.
    Wang, S. A.
    MODERN PATHOLOGY, 2011, 24 : 334A - 334A
  • [13] Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia
    Klimek, Virginia M.
    CURRENT OPINION IN HEMATOLOGY, 2013, 20 (02) : 137 - 143
  • [14] THERAPY-RELATED MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA: ETIOLOGY, PROGNOSIS AND TREATMENT
    Kujawski, E.
    Burnham, M. R.
    Mousa, S. S.
    Mousa, S. A.
    DRUGS OF THE FUTURE, 2010, 35 (03) : 219 - 236
  • [15] A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience
    Maung, Su W.
    Burke, Cathie
    Hayde, Jennifer
    Walshe, Janice
    McDermott, Ray
    Desmond, Ronan
    McHugh, Johnny
    Enright, Helen
    HEMATOLOGY, 2017, 22 (06) : 341 - 346
  • [16] Therapy-Related Myeloid Neoplasms (t-MN) in 71 Patients Following Radiation Therapy (RT) Only
    Lin, Richard J.
    Joshi, Smita
    Le Beau, Michelle M.
    Weiner, Howard
    Green, Peggy
    Karrison, Theodore
    Larson, Richard A.
    BLOOD, 2011, 118 (21) : 1502 - 1502
  • [17] Comparison of prognostic factors and outcomes of patients with secondary acute myeloid leukemia (AML) following myelodysplastic syndromes (MDS), myeloproliferative disorders (MPD), or therapy-related AML (t-AML)
    Mohan, Sanjay
    Elson, Paul
    Rodriguez, Cristina
    Baz, Rachid
    Kalaycio, Matt
    Sobecks, Ronald
    Advani, Anjali
    Maciejewski, Jaroslaw P.
    Copelan, Edward
    Sekeres, Mikkael A.
    BLOOD, 2007, 110 (11) : 140B - 141B
  • [18] CYTOGENETIC STUDY IN THERAPY-RELATED MYELODYSPLASTIC SYNDROMES (T-MDS) AND ACUTE NONLYMPHOCYTIC LEUKEMIA (T-ANLL)
    SOZZI, G
    MIOZZO, M
    ORAZI, A
    CALDERONE, C
    CASTELLANO, M
    VIVIANI, S
    SANTORO, A
    PIEROTTI, MA
    DELLAPORTA, G
    BRITISH JOURNAL OF CANCER, 1990, 61 (03) : 425 - 428
  • [19] Methylenetetrahydrofolate reductase polymorphisms in myelodysplastic syndromes and therapy-related myeloid neoplasms
    Criscuolo, Marianna
    Chiusolo, Patrizia
    Giammarco, Sabrina
    Giachelia, Manuela
    Fianchi, Luana
    Fabiani, Emiliano
    Falconi, Giulia
    Hohaus, Stefan
    Sica, Simona
    Leone, Giuseppe
    Voso, Maria Teresa
    LEUKEMIA & LYMPHOMA, 2014, 55 (12) : 2942 - 2944
  • [20] THERAPY RELATED MYELOID NEOPLASMS (T-MN) SHOW HIGH MUTATION FREQUENCY AND A SPECTRUM DIFFERENT FROM PRIMARY MDS
    Singhal, D.
    Wee, L. A.
    Babic, M.
    Parker, W.
    Moore, S.
    Feng, J.
    Schreiber, A.
    Geoghegan, J.
    Kutyna, M.
    Chhetri, R.
    Nath, S.
    Singhal, N.
    Gowda, R.
    Ross, D.
    To, L. B.
    D'Andrea, R.
    Lewis, I.
    Hahn, C.
    Scott, H.
    Hiwase, D.
    LEUKEMIA RESEARCH, 2017, 55 : S158 - S159
12345